COVID-19 Pandemic Impacts CRISPR Technology Market

The global CRISPR technology market is estimated at US$2,251.21 million in 2021 and is projected to reach US$6,453.96 million by 2027. A compound annual growth rate of 19.45% is expected from 2022 to 2027, according to the latest report on the CRISPR technology market released by ReportLinker.

The highlights of the report include:

•  
• - The COVID-19 pandemic has a positive impact on the market due to an increase in demand for COVID-19 diagnostic tests.
•  
• - North America dominates the CRISPR market and is expected to continue until 2027.
•  
• - Market growth drivers include increasing government and private funding, rising demand and adoption of CRISPR, and technological advancements.
•  
• - The biomedical segment (genome engineering, disease model studies, functional genomics, epigenetics, etc.) holds a significant market share. 

Read the summary of the report from ReportLinker.